Abstract
Intracellular Ca2+ release channels, such as inositol 1,4,5-trisphosphate receptors (IP3Rs) and ryanodine receptors (RyRs), facilitate the release of Ca2+ from intracellular storage organelles in response to extracellular and intracellular stimuli. Consequently, these large, tetrameric proteins play a central role in Ca2+ signalling and Ca2+ homeostasis in virtually all cells. Recent data suggests that intracellular Ca2+ release channels may also have an important pathophysiological function in certain disease states, including cardiac arrhythmias and heart failure. As a result, there has been much interest in the identification and characterization of novel, selective regulators of these channels. In this article, we review the wide array of pharmacological agents that interact directly with intracellular Ca2+ release channels and describe the mechanisms underlying their ability to modify channel function.
Keywords: Ryanodine Receptors, Caffeine, dantrolene, JTV519, PKA hyperphosphorylation, Ruthenium Red
Current Pharmaceutical Design
Title: Pharmacological Regulators of Intracellular Calcium Release Channels
Volume: 13 Issue: 24
Author(s): Duncan J. West and Alan J. Williams
Affiliation:
Keywords: Ryanodine Receptors, Caffeine, dantrolene, JTV519, PKA hyperphosphorylation, Ruthenium Red
Abstract: Intracellular Ca2+ release channels, such as inositol 1,4,5-trisphosphate receptors (IP3Rs) and ryanodine receptors (RyRs), facilitate the release of Ca2+ from intracellular storage organelles in response to extracellular and intracellular stimuli. Consequently, these large, tetrameric proteins play a central role in Ca2+ signalling and Ca2+ homeostasis in virtually all cells. Recent data suggests that intracellular Ca2+ release channels may also have an important pathophysiological function in certain disease states, including cardiac arrhythmias and heart failure. As a result, there has been much interest in the identification and characterization of novel, selective regulators of these channels. In this article, we review the wide array of pharmacological agents that interact directly with intracellular Ca2+ release channels and describe the mechanisms underlying their ability to modify channel function.
Export Options
About this article
Cite this article as:
Duncan J. West and Alan J. Williams , Pharmacological Regulators of Intracellular Calcium Release Channels, Current Pharmaceutical Design 2007; 13 (24) . https://dx.doi.org/10.2174/138161207781368620
DOI https://dx.doi.org/10.2174/138161207781368620 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
T Lymphocytes as Targets of Statins: Molecular Mechanisms and Therapeutic Perspectives
Inflammation & Allergy - Drug Targets (Discontinued) Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Current Drug Targets Nitric Oxide, Malnutrition and Chronic Renal Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry Pharmacology of TRP Channels in the Vasculature
Current Vascular Pharmacology Gender Differences in Metabolic Syndrome – A Key Research Issue
Endocrine, Metabolic & Immune Disorders - Drug Targets Imaging of Organ Metabolism in Obesity and Diabetes: Treatment Perspectives
Current Pharmaceutical Design MicroRNAs in Cancer Therapy: From Bench to Bedside
Current Cancer Therapy Reviews Glucose Oncometabolism of Esophageal Cancer
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Potential of Endothelial Progenitor Cells for Cardiovascular Diseases
Current Vascular Pharmacology Anthocyanins as a Potential Therapy for Diabetic Retinopathy
Current Medicinal Chemistry Fatty Liver and Ischemia/Reperfusion: Are there Drugs Able to Mitigate Injury?
Current Medicinal Chemistry Contemporary Pharmacologic Management of Heart Failure with Reduced Ejection Fraction: A Review
Current Cardiology Reviews Postconditioning: A New Paradigm for Myocardial Protection?
Current Cardiology Reviews Nociceptin /Orphanin FQ Peptide (NOP) Receptor Modulators: An Update in Structure-Activity Relationships
Current Medicinal Chemistry Does A Subclinical Cardiotoxic Effect of Clozapine Exist? Results from a Follow-up Pilot Study
Cardiovascular & Hematological Agents in Medicinal Chemistry Targets for Medical Therapy to Limit Abdominal Aortic Aneurysm Progression
Current Drug Targets Pro- and Anti-Arrhythmic Effects of Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Role of Obesity in Cardiomyopathy and Nephropathy
Current Pharmaceutical Design Between Bench and Bed Side: PI3K Inhibitors
Current Molecular Pharmacology Use of Compound Chinese Medicine in the Treatment of Lung Cancer
Current Drug Discovery Technologies